Mirzaiebadizi A, Shafabakhsh R, Ahmadian M
Biomolecules. 2025; 15(2).
PMID: 40001545
PMC: 11852631.
DOI: 10.3390/biom15020242.
Barrett T, Patel B, Khan S, Mullins R, Yim A, Pugazenthi S
Nat Commun. 2024; 15(1):478.
PMID: 38216553
PMC: 10786875.
DOI: 10.1038/s41467-023-42762-w.
Dougherty M, Shibata S, Clark J, Canady F, Yates C, Hansen M
J Neurosurg. 2022; 138(4):962-971.
PMID: 36087315
PMC: 10193498.
DOI: 10.3171/2022.7.JNS22934.
Zhang Y, Long J, Ren J, Huang X, Zhong P, Wang B
Front Oncol. 2021; 11:731441.
PMID: 34646772
PMC: 8503266.
DOI: 10.3389/fonc.2021.731441.
Dougherty M, Shibata S, Hansen M
Laryngoscope Investig Otolaryngol. 2021; 6(3):458-468.
PMID: 34195368
PMC: 8223465.
DOI: 10.1002/lio2.553.
Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling.
Chen Z, Li S, Mo J, Hawley E, Wang Y, He Y
JCI Insight. 2020; 5(20).
PMID: 32960816
PMC: 7605536.
DOI: 10.1172/jci.insight.141514.
Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas.
Loewenstern J, Rutland J, Gill C, Arib H, Pain M, Umphlett M
Oncotarget. 2019; 10(37):3506-3517.
PMID: 31191822
PMC: 6544407.
DOI: 10.18632/oncotarget.26941.
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
White S, Avantaggiati M, Nemazanyy I, Di Poto C, Yang Y, Pende M
Dev Cell. 2019; 49(3):425-443.e9.
PMID: 31063758
PMC: 6524954.
DOI: 10.1016/j.devcel.2019.04.014.
An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.
Stepanova D, Semenova G, Kuo Y, Andrews A, Ammoun S, Hanemann C
Cancer Res. 2017; 77(18):5026-5038.
PMID: 28729415
PMC: 5600854.
DOI: 10.1158/0008-5472.CAN-16-2834.
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses Loss-Driven Tumorigenesis.
Cooper J, Xu Q, Zhou L, Pavlovic M, Ojeda V, Moulick K
Mol Cancer Ther. 2017; 16(8):1693-1704.
PMID: 28468780
PMC: 5929164.
DOI: 10.1158/1535-7163.MCT-16-0821.
Molecular Mechanisms Involved in Schwann Cell Plasticity.
Boerboom A, Dion V, Chariot A, Franzen R
Front Mol Neurosci. 2017; 10:38.
PMID: 28261057
PMC: 5314106.
DOI: 10.3389/fnmol.2017.00038.
Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.
Bassiri K, Ferluga S, Sharma V, Syed N, Adams C, Lasonder E
EBioMedicine. 2017; 16:76-86.
PMID: 28126595
PMC: 5474504.
DOI: 10.1016/j.ebiom.2017.01.020.
Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.
Shi Y, Bollam S, White S, Laughlin S, Graham G, Wadhwa M
Dev Cell. 2016; 39(4):452-465.
PMID: 27818180
PMC: 5519326.
DOI: 10.1016/j.devcel.2016.09.027.
Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.
Mercado-Pimentel M, Miller C, Rolph D, Villalobos E, Dunn A, Mohan P
Otol Neurotol. 2016; 38(1):139-146.
PMID: 27755359
PMC: 5154791.
DOI: 10.1097/MAO.0000000000001247.
Role of Merlin/NF2 inactivation in tumor biology.
Petrilli A, Fernandez-Valle C
Oncogene. 2015; 35(5):537-48.
PMID: 25893302
PMC: 4615258.
DOI: 10.1038/onc.2015.125.
The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.
Ammoun S, Schmid M, Zhou L, Hilton D, Barczyk M, Hanemann C
Mol Oncol. 2014; 9(1):236-48.
PMID: 25217104
PMC: 5528691.
DOI: 10.1016/j.molonc.2014.08.005.
Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.
Lu Y, Liu X, Jiao Y, Xiong X, Wang E, Wang X
J Clin Invest. 2014; 124(8):3501-13.
PMID: 25003192
PMC: 4109546.
DOI: 10.1172/JCI74438.
p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB.
Ahmad I, Yue W, Fernando A, Clark J, Woodson E, Hansen M
Glia. 2014; 62(10):1699-712.
PMID: 24976126
PMC: 4150679.
DOI: 10.1002/glia.22709.
Mitogen Activated Protein Kinase Family Proteins and c-jun Signaling in Injury-induced Schwann Cell Plasticity.
Lee H, Shin Y, Park H
Exp Neurobiol. 2014; 23(2):130-7.
PMID: 24963277
PMC: 4065826.
DOI: 10.5607/en.2014.23.2.130.
Uridine 5'-triphosphate promotes in vitro Schwannoma cell migration through matrix metalloproteinase-2 activation.
Lamarca A, Gella A, Martianez T, Segura M, Figueiro-Silva J, Grijota-Martinez C
PLoS One. 2014; 9(6):e98998.
PMID: 24905332
PMC: 4048211.
DOI: 10.1371/journal.pone.0098998.